ELI LILLY & Co·4

Feb 14, 4:31 PM ET

Ricks David A 4

4 · ELI LILLY & Co · Filed Feb 14, 2024

Insider Transaction Report

Form 4
Period: 2024-02-12
Ricks David A
DirectorPresident, Chair, and CEO
Transactions
  • Award

    Common Stock

    2024-02-12$737.26/sh+38,392$28,304,886479,250 total
  • Award

    Restricted Stock Unit

    2024-02-12+26,56126,561 total
    From: 2025-02-01Exp: 2025-02-01Common Stock (26,561 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    7,223
  • Common Stock

    (indirect: By David A. Ricks SLAT)
    68,656
  • Common Stock

    (indirect: By David A. Ricks 2022 GRAT)
    63,758
Footnotes (2)
  • [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file
  • 4
    wk-form4_1707946275.xmlPrimary

    FORM 4